Kurma Growth Opportunities Fund

Kurma Partners focuses on funding healthcare and biotechnology companies in Europe, spanning from company creation to capital expansion. They aim to transform disruptive scientific discoveries from leading European academic research into cutting-edge medicines and medical devices. Their approach involves working closely with research teams early on to validate discoveries, bring together healthcare industry experts and experienced entrepreneurs to create high-tech companies. They provide capital and invite other investors, aiming to build the healthcare industry of tomorrow and have a positive impact on sustainable development through their ESG practices. Kurma's investment strategy centers around building companies from the ground up, often collaborating directly with research centers to identify and validate promising scientific breakthroughs. They actively participate in the early stages, providing not only capital but also expertise and a network of industry professionals to guide the companies' development. This hands-on approach differentiates them from other healthcare investors, enabling them to shape the direction and growth of their portfolio companies. The firm's commitment to ESG principles is evident in their dedication to sustainable development within the healthcare sector. They seek to contribute positively to the industry's future by supporting companies that address unmet medical needs and drive innovation. By investing in companies with a strong potential for growth and impact, Kurma Partners aims to generate both financial returns and societal benefits. Their unique approach enables them to build more than 10 companies over the past 10 years and finance more than 40 companies, many of which have become recognized leaders in their respective sectors.

Healthcare, Biotechnology, Diagnostics, Medical Devices, Therapeutics

Core thematic spaces, technologies, and target market segments of interest.